Last reviewed · How we verify
NCT05542160
Effectiveness of IRK-19® on Body Weight Control
NA trial testing Pumpkin seed extract (IRK-19) in Overweight in 50 participants. Completed in 30 June 2024.
29 February 2024
Quick facts
| Lead sponsor | Greenyn Biotechnology Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 50 |
| Start date | 1 October 2022 |
| Primary completion | 29 February 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Pumpkin seed extract (IRK-19)
Conditions studied
- Overweight — all drugs for Overweight →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
Sponsor
Greenyn Biotechnology Co., Ltd.
Who can join
Adults 20 to 60, any sex, with Overweight or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract (IRK-19®) on weight management.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05542160
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
- NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
- NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting
Other Greenyn Biotechnology Co., Ltd. trials
Trials by the same sponsor.
- NCT05728918 — Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People · NA · completed
- NCT05738655 — Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects · NA · unknown
- NCT05309161 — Efficacy Testing of Crassocephalum Rabens Extract Capsules · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05542160 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Greenyn Biotechnology Co., Ltd.
- Last refreshed: 9 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05542160.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing